8-K   

UNITED STATES  

SECURITIES AND EXCHANGE COMMISSION  

WASHINGTON, D.C. 20549  

FORM 8-K  

CURRENT REPORT  

Pursuant to Section 13 OR 15(d)  

of the Securities Exchange Act of 1934  

Date of Report (Date of earliest event reported): January 20, 2015  

ENDO INTERNATIONAL PLC  

(Exact Name of Registrant as Specified in Charter)  

  [DATA_TABLE_REMOVED] 

Minerva House, Simmonscourt Road, Ballsbridge, Dublin 4, Ireland  

(Address of principal executive offices)  

Registrant’s telephone number, including area code 011-353-1-268-2000  

Not Applicable  

Former name or former address, if changed since last report  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  

 ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  

 ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  

 ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  

 ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  

 Item 8.01. Other Events.  

On January 20, 2015, Endo International plc issued a press release announcing the commencement of a private offering (the “Offering”) of a new series of senior unsecured notes (the “Notes”) by its wholly-owned subsidiaries, Endo Limited, Endo Finance LLC and Endo Finco Inc.  

A copy of the press release announcing the commencement of the Offering is filed herewith as Exhibit 99.1 and is incorporated herein by reference.  

The Notes have not been registered under the Securities Act of 1933, as amended, and may not be offered in the United States absent registration or an applicable exemption from registration requirements.  

 Item 9.01 Financial Statements and Exhibits.  

(d) Exhibits.  

 99.1   Press Release of Endo International plc, dated January 20, 2015, related to the commencement of the Offering.  

2  

SIGNATURE  

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.  

Dated: January 20, 2015  

 [DATA_TABLE_REMOVED] 

3  

Index of Exhibits  

Exhibit 

Number    Description 

 99.1   Press Release of Endo International plc, dated January 20, 2015, related to the commencement of the Offering.  

4